Jacobson Mark L.
Chief Operating Officer · 12 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-05 | AXSM | Axsome Therapeutics, Inc. | Sale | 233 | $228.18 | $53,165.94 | filing |
| 2026-05-05 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 233 | $12.95 | $3,017.35 | filing |
| 2026-05-04 | AXSM | Axsome Therapeutics, Inc. | Sale | 4,517 | $227.94 | $1.0M | filing |
| 2026-05-04 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 4,517 | $12.95 | $58,495.15 | filing |
| 2026-02-26 | AXSM | Axsome Therapeutics, Inc. | Sale | 35,378 | $161.88 | $5.7M | filing |
| 2026-02-26 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 35,378 | $2.85 | $100,827.30 | filing |
| 2025-09-22 | AXSM | Axsome Therapeutics, Inc. | Sale | 10,000 | $115.96 | $1.2M | filing |
| 2025-09-22 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 10,000 | $2.85 | $28,500.00 | filing |
| 2025-09-16 | AXSM | Axsome Therapeutics, Inc. | Sale | 40,000 | $114.23 | $4.6M | filing |
| 2025-09-16 | AXSM | Axsome Therapeutics, Inc. | Sale | 5,783 | $116.19 | $671,926.77 | filing |
| 2025-09-16 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 25,000 | $4.95 | $123,750.00 | filing |
| 2025-09-16 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 15,000 | $4.85 | $72,750.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.